Immunome, Inc.

IMNM stock score: 41/100

$18.00 · +0.45% · Scored Oct 21, 2026

Technical
50
Fundamental
33
News
52

The reading

Immunome (IMNM) scores 41 out of 100, which reads weak, higher than 38% of Healthcare stocks and 22% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 50, fundamentals 33.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 26 and contrarian oscillators 67 — a split worth reading before trusting the technical total.

News sentiment is neutral at 52; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 37 to 72, and it is down 27 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward IMNM’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

33

Pulling it up

  • Quick Ratio100

    Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Current Ratio100

    Current ratio measures ability to pay short-term liabilities with current assets.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Price to Sales Ratio0

    Price-to-Sales ratio compares market capitalization to annual revenue.

37 weighted scorers; 4 had no data today and are left out rather than counted as zero.

Technical · daily

31

Pulling it up

  • SMA 589

    Simple Moving Average (5-period) tracks the average price over the last 5 periods.

  • Candlestick Patterns88

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • RSI (14)87

    Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

Holding it back

  • Performance vs SPY0

    Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • SMA Trend 200

    SMA 20 Trend tracks the direction and steepness of the 20-period average.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
52

Technical score by timeframe

ChartScoreWeight
Hourly571
Daily313
Weekly462
Monthly592
Quarterly692

Composite score, last 90 days

05010041Jul 25, 2026Oct 21, 2026Jul 25, 2026: 68Jul 26, 2026: 68Jul 27, 2026: 68Jul 28, 2026: 69Jul 29, 2026: 71Jul 30, 2026: 72Jul 31, 2026: 57Aug 2, 2026: 53Aug 3, 2026: 53Aug 5, 2026: 54Aug 6, 2026: 54Aug 7, 2026: 54Aug 8, 2026: 55Aug 9, 2026: 55Aug 10, 2026: 55Aug 11, 2026: 56Aug 12, 2026: 57Aug 13, 2026: 55Aug 14, 2026: 56Aug 15, 2026: 56Aug 16, 2026: 56Aug 17, 2026: 57Aug 18, 2026: 57Aug 19, 2026: 57Aug 20, 2026: 56Aug 22, 2026: 51Aug 23, 2026: 51Aug 24, 2026: 51Aug 25, 2026: 52Aug 26, 2026: 51Aug 27, 2026: 52Aug 28, 2026: 50Aug 29, 2026: 51Aug 30, 2026: 50Aug 31, 2026: 50Sep 1, 2026: 51Sep 2, 2026: 51Sep 3, 2026: 56Sep 4, 2026: 49Sep 5, 2026: 50Sep 6, 2026: 49Sep 7, 2026: 50Sep 8, 2026: 51Sep 9, 2026: 48Sep 10, 2026: 47Sep 11, 2026: 47Sep 12, 2026: 47Sep 13, 2026: 47Sep 14, 2026: 48Sep 15, 2026: 46Sep 16, 2026: 45Sep 17, 2026: 47Sep 18, 2026: 47Sep 19, 2026: 47Sep 20, 2026: 47Sep 21, 2026: 49Sep 22, 2026: 50Sep 23, 2026: 51Sep 24, 2026: 46Sep 25, 2026: 43Sep 26, 2026: 43Sep 27, 2026: 43Sep 28, 2026: 43Sep 29, 2026: 44Sep 30, 2026: 44Oct 1, 2026: 42Oct 2, 2026: 43Oct 3, 2026: 43Oct 4, 2026: 43Oct 5, 2026: 43Oct 6, 2026: 41Oct 7, 2026: 41Oct 8, 2026: 41Oct 9, 2026: 42Oct 10, 2026: 42Oct 11, 2026: 42Oct 12, 2026: 41Oct 13, 2026: 39Oct 14, 2026: 38Oct 15, 2026: 38Oct 16, 2026: 37Oct 17, 2026: 38Oct 18, 2026: 38Oct 19, 2026: 38Oct 20, 2026: 40Oct 21, 2026: 41
Show the daily numbers
DateComposite
Oct 21, 202641
Oct 20, 202640
Oct 19, 202638
Oct 18, 202638
Oct 17, 202638
Oct 16, 202637
Oct 15, 202638
Oct 14, 202638
Oct 13, 202639
Oct 12, 202641
Oct 11, 202642
Oct 10, 202642
Oct 9, 202642
Oct 8, 202641
Oct 7, 202641
Oct 6, 202641
Oct 5, 202643
Oct 4, 202643
Oct 3, 202643
Oct 2, 202643
Oct 1, 202642
Sep 30, 202644
Sep 29, 202644
Sep 28, 202643
Sep 27, 202643
Sep 26, 202643
Sep 25, 202643
Sep 24, 202646
Sep 23, 202651
Sep 22, 202650
Sep 21, 202649
Sep 20, 202647
Sep 19, 202647
Sep 18, 202647
Sep 17, 202647
Sep 16, 202645
Sep 15, 202646
Sep 14, 202648
Sep 13, 202647
Sep 12, 202647
Sep 11, 202647
Sep 10, 202647
Sep 9, 202648
Sep 8, 202651
Sep 7, 202650
Sep 6, 202649
Sep 5, 202650
Sep 4, 202649
Sep 3, 202656
Sep 2, 202651
Sep 1, 202651
Aug 31, 202650
Aug 30, 202650
Aug 29, 202651
Aug 28, 202650
Aug 27, 202652
Aug 26, 202651
Aug 25, 202652
Aug 24, 202651
Aug 23, 202651
Aug 22, 202651
Aug 20, 202656
Aug 19, 202657
Aug 18, 202657
Aug 17, 202657
Aug 16, 202656
Aug 15, 202656
Aug 14, 202656
Aug 13, 202655
Aug 12, 202657
Aug 11, 202656
Aug 10, 202655
Aug 9, 202655
Aug 8, 202655
Aug 7, 202654
Aug 6, 202654
Aug 5, 202654
Aug 3, 202653
Aug 2, 202653
Jul 31, 202657
Jul 30, 202672
Jul 29, 202671
Jul 28, 202669
Jul 27, 202668
Jul 26, 202668
Jul 25, 202668

Key facts

Market cap
$2.1B
Sector
Healthcare
Industry
Biotechnology
Beta
2.56
Risk grade (1–10)
9
Next earnings
Nov 5, 2026

Biotechnology peers

CompanyMarket capScore
AGIO Agios Pharmaceuticals$2.2B49
PHVS Pharvaris$2.2B43
FTRE Fortrea$2.2B52
VERA Vera Therapeutics$2.2B36
VCEL Vericel$2.1B55
SRPT Sarepta Therapeutics$2.0B39

Questions

What is IMNM's stock score today?

IMNM scores 41/100 (Weak) as of Oct 21, 2026: technical 50, fundamental 33, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.

Is IMNM a buy?

The score is not a buy or sell recommendation. A 41 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the IMNM score calculated?

99 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.